Yes, thank you, Chair.
This amendment comes primarily out of the testimony of Mr. Herder. We know that Mr. Young has a similar amendment. However, we believe that our amendment provides for a mandatory process that explicitly lays out in the act a public registry, as opposed to defining this in the regulations, and improves the safety and efficacy of therapeutic products.
Our amendment seeks, first, to ensure that all clinical trials and investigational tests are registered with the minister; second, that therapeutic product authorization would not be issued unless it were registered; and third, that results must be provided to the minister no later than one year after their completion—